“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
It’s a new frontier in the fight against cancer: An experimental therapy aims to “teach” a patient’s own immune system to recognize and kill cancer cells. For Nick Wilkins, a now 15-year-old boy whose leukemia had defied all other attempts at treatment, the investigational therapy was a game-changer: He has now been cancer-free for six months. As reported at the annual…
Professor Yehuda Shoenfeld, a prominent researcher and clinician specializing in autoimmune and rheumatic diseases, talked with BioMed Central about his observation of a correlation between autoimmune disorders and one of four distinct conditions associated with previous exposure to an adjuvant, which is an agent added to intensify a desired reaction.
Traditionally, treatment is determined by what works for the majority of people. However, the majority is not everyone. And, the flip side of life-saving effects of a popular medicine is the possibility of harmful effects from that same medicine. In the era of personalized medicine, there may be a way to lower the risk of prescription drug reactions through genomics. The…